MedPath

Preservation vs. Dissection of Inferior Pulmonary Ligament for Thoracoscopic Upper Lobectomy

Not Applicable
Completed
Conditions
Lung Diseases
Interventions
Procedure: Dissection of the Inferior Pulmonary Ligament
Procedure: Preservation of the Inferior Pulmonary Ligament
Registration Number
NCT04120155
Lead Sponsor
Fujian Medical University Union Hospital
Brief Summary

Many thoracic surgeons tend to dissect the inferior pulmonary ligament (IPL) during upper lobectomy, which in theory reduces the free space in the upper thoracic cavity by increasing the mobility of the residual lung. However, the dissection of IPL may lead to bronchial deformation, stenosis, obstruction or lobe torsion, and distortion. Some studies have found that stenosis might be associated with chronic dry cough and shortness of breath, and could result in a significant decline in lung function. Moreover, the dissection of IPL may lead to greater surgical trauma and increase the incidence of complications. Therefore, this study tries to identify whether we should dissect or preserve the inferior pulmonary ligament during the thoracoscopic upper lobectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
270
Inclusion Criteria
  1. 18 years old < age < 70 years old;
  2. Meet the indications for thoracoscopic left/right upper lobectomy;
  3. Gave informed consent and were willing to undergo thoracoscopic left/right upper lobectomy;
  4. Preoperative pulmonary function test: FEV1>1L and FEV1>60% of the predicted value;
  5. Preoperative ECOG score of 0-1;
  6. Preoperative ASA score I-II.
Exclusion Criteria
  1. Inferior mediastinal lymphadenopathy was found in preoperative screening;
  2. Found that other lobe operations were required at the same time due to multiple lesions in the preoperative discussion;
  3. Pregnant or lactating women;
  4. Suffering from severe mental illness;
  5. History of thoracic surgery (including intrathoracic surgery only, excluding surface surgery such as mastectomy);
  6. History of unstable angina or myocardial infarction within the past six months;
  7. History of cerebral infarction or cerebral hemorrhage within the past six months;
  8. History of continuous systemic corticosteroid therapy within the past month;
  9. Abnormal coagulation function, bleeding tendency, or receiving antithrombotic or antiplatelet therapy recently;
  10. Suffering from severe liver, kidney, and other systemic diseases;
  11. Other situations that are not suitable for surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dissecting the inferior pulmonary ligamentDissection of the Inferior Pulmonary LigamentThis group of patients will undergo the inferior pulmonary dessection during the upper lobe thoractomy.
Preserving the inferior pulmonary ligamentPreservation of the Inferior Pulmonary LigamentThis group of patients will undergo the inferior pulmonary preservation during the upper lobe thoractomy.
Primary Outcome Measures
NameTimeMethod
Change in bronchial angle6 months after the operation

Change in bronchial angle of each arm(measured by coronal CT)

Change in lung volume6 months after the operation

Change in lung volume of each arm(measured by Mimics Research 21.0 software)

Secondary Outcome Measures
NameTimeMethod
Apical dead spaceWithin 6 months after the operation

Apical dead space incidence rate

Lung infectionWithin 6 months after the operation

Lung infection incidence rate

Closed thoracic drainage tube rentention timeDuring the postoperative hospital stay

Closed thoracic drainage tube rentention time

Pathologic cancer stageAfter the operation

Pathologic cancer stage

Atrial fibrillationDuring the postoperative hospital stay

Atrial fibrillation incidence rate

Operation timeDuring the operation

Operation time

Disposable drainage catheter retention timeWithin one month after the operation

Disposable drainage catheter retention time

Pleural effusionWithin 6 months after the operation

Pleural effusion incidence rate

Postoperative hospital stayDuring the postoperative hospital stay

Postoperative hospital stay

Histologic diagnosisAfter the operation

Histologic diagnosis

Trial Locations

Locations (1)

Fujian Medical University Union Hospital

🇨🇳

Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath